$AMRN
AMARIN CORP PLC\UK

2021 Q3 Form 10-Q Financial Statement

#000095017021002721 Filed on November 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q2
Revenue $142.0M $156.5M $135.3M
YoY Change -9.24% 39.22% 34.25%
Cost Of Revenue $30.21M $33.07M $28.80M
YoY Change -8.65% 29.98% 26.47%
Gross Profit $111.8M $123.4M $106.5M
YoY Change -9.4% 41.93% 36.53%
Gross Profit Margin 78.73% 78.87% 78.72%
Selling, General & Admin $103.0M $120.2M $92.40M
YoY Change -14.31% 45.55% 25.87%
% of Gross Profit 92.08% 97.36% 86.74%
Research & Development $7.820M $10.20M $9.969M
YoY Change -23.36% 14.36% 39.82%
% of Gross Profit 6.99% 8.27% 9.36%
Depreciation & Amortization $780.0K $511.0K $510.0K
YoY Change 52.64% 145.67% 214.81%
% of Gross Profit 0.7% 0.41% 0.48%
Operating Expenses $124.9M $130.4M $102.4M
YoY Change -4.19% 42.51% 27.1%
Operating Profit -$13.07M -$6.940M $4.156M
YoY Change 88.37% 53.61% -265.31%
Interest Expense $163.0K $549.0K $151.0K
YoY Change -70.31% -52.09% -80.86%
% of Operating Profit 3.63%
Other Income/Expense, Net -$57.00K $33.00K $108.0K
YoY Change -272.73% -136.67% -213.68%
Pretax Income -$12.97M -$6.358M $4.415M
YoY Change 103.95% 83.65% -342.58%
Income Tax $184.0K $430.0K $0.00
% Of Pretax Income 0.0%
Net Earnings -$13.15M -$6.788M $4.415M
YoY Change 93.74% 96.07% -342.58%
Net Earnings / Revenue -9.26% -4.34% 3.26%
Basic Earnings Per Share -$0.03 -$0.02 $0.01
Diluted Earnings Per Share -$0.03 -$0.02 $0.01
COMMON SHARES
Basic Shares Outstanding 396.6M 389.7M 384.7M
Diluted Shares Outstanding 396.6M 389.7M 399.7M

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $479.1M $561.9M $550.3M
YoY Change -14.72% -16.54% 148.13%
Cash & Equivalents $222.9M $207.2M $214.0M
Short-Term Investments $256.3M $354.7M $336.3M
Other Short-Term Assets $25.26M $30.86M $27.50M
YoY Change -18.14% 84.1% 219.57%
Inventory $309.3M $148.5M $124.8M
Prepaid Expenses
Receivables $149.4M $147.3M $125.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $963.0M $888.5M $827.6M
YoY Change 8.38% 4.76% 122.47%
LONG-TERM ASSETS
Property, Plant & Equipment $1.569M $10.32M $10.61M
YoY Change -84.79% 385.64% 1136.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $38.80M $46.09M $61.04M
YoY Change -15.82%
Other Assets $456.0K $1.074M $1.074M
YoY Change -57.54% 0.0% -2.54%
Total Long-Term Assets $72.80M $71.70M $87.27M
YoY Change 1.53% 280.63% 386.94%
TOTAL ASSETS
Total Short-Term Assets $963.0M $888.5M $827.6M
Total Long-Term Assets $72.80M $71.70M $87.27M
Total Assets $1.036B $960.2M $914.9M
YoY Change 7.87% 10.76% 134.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.42M $121.4M $86.76M
YoY Change -40.33% 188.68% 155.03%
Accrued Expenses $289.7M $189.7M $168.5M
YoY Change 52.75% 40.96% 62.86%
Deferred Revenue $2.646M $5.706M
YoY Change 190.83%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $9.500M $22.46M
YoY Change -81.43% -50.55%
Total Short-Term Liabilities $364.7M $326.2M $283.5M
YoY Change 11.82% 42.0% 53.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $5.350M $26.76M $4.821M
YoY Change -80.01% 395.32% -29.24%
Total Long-Term Liabilities $5.350M $26.76M $4.821M
YoY Change -80.01% 87.37% -83.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $364.7M $326.2M $283.5M
Total Long-Term Liabilities $5.350M $26.76M $4.821M
Total Liabilities $393.3M $352.9M $312.1M
YoY Change 11.44% 30.22% 29.59%
SHAREHOLDERS EQUITY
Retained Earnings -$1.436B -$1.427B
YoY Change 0.89%
Common Stock $293.1M $285.7M
YoY Change 14.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $59.60M $50.25M
YoY Change 144.74%
Treasury Stock Shares $7.159M $5.742M
Shareholders Equity $642.5M $607.3M $602.8M
YoY Change
Total Liabilities & Shareholders Equity $1.036B $960.2M $914.9M
YoY Change 7.87% 10.76% 134.63%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$13.15M -$6.788M $4.415M
YoY Change 93.74% 96.07% -342.58%
Depreciation, Depletion And Amortization $780.0K $511.0K $510.0K
YoY Change 52.64% 145.67% 214.81%
Cash From Operating Activities -$4.540M $10.85M $1.587M
YoY Change -141.83% -50.1% -90.02%
INVESTING ACTIVITIES
Capital Expenditures -$1.000K $0.00
YoY Change -99.92% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$99.49M -$4.358M -$102.5M
YoY Change 2182.95%
Cash From Investing Activities -$99.49M -$4.359M -$102.5M
YoY Change 2182.43% 231.99% 12692.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -110.0K -13.29M -14.15M
YoY Change -99.17% -103.07% 219.86%
NET CHANGE
Cash From Operating Activities -4.540M 10.85M 1.587M
Cash From Investing Activities -99.49M -4.359M -102.5M
Cash From Financing Activities -110.0K -13.29M -14.15M
Net Change In Cash -104.1M -6.798M -115.0M
YoY Change 1431.94% -101.5% -1176.8%
FREE CASH FLOW
Cash From Operating Activities -$4.540M $10.85M $1.587M
Capital Expenditures -$1.000K $0.00
Free Cash Flow $10.85M $1.587M
YoY Change -52.94% -90.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Assets
Assets
1035805000
CY2020Q4 us-gaap Assets
Assets
966021000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
72415000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
105876000
CY2021Q3 amrn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
289684000
CY2020Q4 amrn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
198641000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2646000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2926000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
364745000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
307443000
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
14486000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
15706000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8729000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9153000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5350000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6214000
CY2021Q3 us-gaap Liabilities
Liabilities
393310000
CY2020Q4 us-gaap Liabilities
Liabilities
338516000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
402772229
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
395613406
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
398425000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
392538081
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000897448
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201912Member
dei Document Type
DocumentType
10-Q
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1845103000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1817649000
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
7158823
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5886919
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
59602000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
51082000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1436146000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1429177000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
642495000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
627505000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1035805000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
966021000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142038000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156499000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
438696000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
446809000
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-21392
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
X0
dei Entity Address Address Line1
EntityAddressAddressLine1
77 Sir John Rogerson’s Quay
dei Entity Address Address Line2
EntityAddressAddressLine2
Block C
dei Entity Address Address Line3
EntityAddressAddressLine3
Grand Canal Docklands
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
293140000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
290115000
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
2
dei Entity Address Country
EntityAddressCountry
IE
dei City Area Code
CityAreaCode
353 (0) 1
dei Local Phone Number
LocalPhoneNumber
6699 020
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30947000
dei Security12b Title
Security12bTitle
American Depositary Shares (ADS(s)), each ADSrepresenting the right to receive one (1) Ordinary Share ofAmarin Corporation plc
dei Trading Symbol
TradingSymbol
AMRN
CY2021Q3 us-gaap Assets Current
AssetsCurrent
963033000
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q4 us-gaap Assets Current
AssetsCurrent
879233000
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
222875000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
186964000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3917000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3915000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
256267000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
313969000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
149361000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
154574000
CY2021Q3 us-gaap Inventory Net
InventoryNet
309268000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1569000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2016000
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
38802000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
62469000
CY2021Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.amarincorp.com/20210930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2020Q4 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2021Q3 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Registrant Name
EntityRegistrantName
AMARIN CORP PLC\UK
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7762000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8054000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
456000
CY2020Q4 us-gaap Inventory Net
InventoryNet
188864000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21345000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
432000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24183000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13817000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30211000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33071000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5631000
us-gaap Operating Income Loss
OperatingIncomeLoss
-26813000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90692000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
96676000
CY2021Q3 us-gaap Gross Profit
GrossProfit
111827000
CY2020Q3 us-gaap Gross Profit
GrossProfit
123428000
us-gaap Gross Profit
GrossProfit
348004000
us-gaap Gross Profit
GrossProfit
350133000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
102965000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
120164000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
315966000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
346496000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7820000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10204000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23554000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30450000
CY2021Q3 us-gaap Restructuring Charges
RestructuringCharges
14115000
us-gaap Restructuring Charges
RestructuringCharges
14115000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
124900000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
130368000
us-gaap Operating Expenses
OperatingExpenses
353635000
us-gaap Operating Expenses
OperatingExpenses
376946000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13073000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6940000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
163000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
549000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
919000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1908000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-57000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-390000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
50000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12967000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6358000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5102000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24855000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
184000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
430000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1867000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1929000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-13151000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6788000
us-gaap Net Income Loss
NetIncomeLoss
-6969000
us-gaap Net Income Loss
NetIncomeLoss
-22926000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
608263000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1306000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12131000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
4415000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
602763000
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-28000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
203000
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-476000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11583000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-6788000
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
396618000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
389699000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
395681000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
378770000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
396618000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
389699000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
395681000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
378770000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
627505000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2059000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-7252000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13925000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1626000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
634611000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1028000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
75000
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-677000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2479000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7808000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
645324000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
481000
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-591000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10432000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-13151000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
642495000
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-13831000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10591000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20553000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
585776000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
848000
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-238000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
352000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-521000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
607257000
amrn Disposal Purchase Of Furniture Fixtures And Equipment
DisposalPurchaseOfFurnitureFixturesAndEquipment
4000
amrn Disposal Purchase Of Furniture Fixtures And Equipment
DisposalPurchaseOfFurnitureFixturesAndEquipment
-252000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
79087000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-400649000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1028000
us-gaap Profit Loss
ProfitLoss
-6969000
us-gaap Profit Loss
ProfitLoss
-22926000
amrn Depreciation And Amortization Excluding Amortization Of Intangible Assets
DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets
443000
amrn Depreciation And Amortization Excluding Amortization Of Intangible Assets
DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets
446000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1564000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-771000
us-gaap Share Based Compensation
ShareBasedCompensation
26836000
us-gaap Share Based Compensation
ShareBasedCompensation
34305000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
601000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1633000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1081000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5213000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30862000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
120404000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
71762000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9601000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13023000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
24000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-723000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1732000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-348000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1500000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1941000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
45582000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
121240000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-995000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
727000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38297000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16577000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
312150000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
186714000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
233067000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
587111000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
848000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2615000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1861000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
266000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
40916000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8520000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14828000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4877000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-53301000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
35913000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-437373000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
190879000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
648495000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
226792000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
211122000
us-gaap Interest Paid Net
InterestPaidNet
1882000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3670000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-197000
amrn Non Cash Or Part Non Cash Milestone Payment
NonCashOrPartNonCashMilestonePayment
12000000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q3 us-gaap Assets
Assets
1035800000
CY2021Q3 amrn Cash And Liquid Short Term And Long Term Investments
CashAndLiquidShortTermAndLongTermInvestments
517900000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
963000000.0
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
222900000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
256300000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
149400000
CY2021Q3 us-gaap Inventory Net
InventoryNet
309300000
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
38800000
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0
amrn Accounts Receivable Credit Period
AccountsReceivableCreditPeriod
P30D
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2021Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
229138000
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
203875000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
149361000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
154574000
CY2021Q3 amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-13151000
CY2020Q3 amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-6788000
amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-6969000
amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-22926000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
396618
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
389699
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
395681
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
378770
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:13.5pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of Credit Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, short-term and long-term investments, and accounts receivable. The Company maintains substantially all of its cash and cash equivalents and short-term and long-term investments, in financial institutions believed to be of high-credit quality.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A significant portion of the Company’s sales are to wholesalers in the pharmaceutical industry. The Company monitors the creditworthiness of customers to whom it grants credit terms and has not experienced any credit losses. The Company does not require collateral or any other security to support credit sales. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Three</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> customers individually accounted for 10% or more of the Company’s gross product sales, Customers A, B, and C accounted for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, of gross product sales for the nine months ended September 30, 2021, and represented </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, of the gross accounts receivable balance as of September 30, 2021. Customers A, B, and C accounted for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, of gross product sales for the nine months ended September 30, 2020 and represented </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, of the gross accounts receivable balance as of September 30, 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company has not experienced any significant write-offs of its accounts receivable. All customer accounts are actively managed and no losses in excess of amounts reserved are currently expected; however, the Company is monitoring the potential negative impact of COVID-19 on the Company’s customers’ ability to meet their financial obligations.</span></p>
us-gaap Debt Instrument Term
DebtInstrumentTerm
P24M
CY2021Q3 amrn Held To Maturity Securities Continuous Unrealized Gain Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedGainLossPositionFairValue
100000
CY2020Q3 amrn Held To Maturity Securities Continuous Unrealized Gain Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedGainLossPositionFairValue
900000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q3 amrn Number Of Sales Representatives
NumberOfSalesRepresentatives
300
CY2021Q3 us-gaap Restructuring Charges
RestructuringCharges
14100000
us-gaap Restructuring Charges
RestructuringCharges
14100000
us-gaap Restructuring Charges
RestructuringCharges
14115000
us-gaap Restructuring Reserve Translation And Other Adjustment
RestructuringReserveTranslationAndOtherAdjustment
-306000
CY2021Q3 us-gaap Restructuring Reserve
RestructuringReserve
13809000
CY2021Q3 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
CY2021Q3 us-gaap Change In Accounting Principle Accounting Standards Update Adoption Date
ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
2021-01-01
CY2021Q3 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P9Y6M
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32081000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20081000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7898000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6264000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24183000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13817000
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
71838000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
50657000
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
39521000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
30388000
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
197909000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
107819000
CY2021Q3 us-gaap Inventory Net
InventoryNet
309268000
CY2020Q4 us-gaap Inventory Net
InventoryNet
188864000
CY2021Q3 us-gaap Purchase Obligation
PurchaseObligation
213000000.0
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2015Q1 amrn Equity Offering Costs
EquityOfferingCosts
700000
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
994921
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
642756
amrn Proceeds From Stock Options Exercised Gross
ProceedsFromStockOptionsExercisedGross
2616050
amrn Proceeds From Stock Options Exercised Gross
ProceedsFromStockOptionsExercisedGross
1861000
CY2020Q4 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
190827000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
627571000
amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
854000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
362460000
amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
172378000
CY2021Q3 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
282706000
CY2019Q4 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
128557000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
585206000
amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
3872000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
384035000
amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
118742000
CY2020Q3 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
207114000
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18632000
amrn Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
92000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1592000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17132000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20846000
amrn Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
3750000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5691000
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18905000
amrn Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period
ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod
1555000
amrn Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period
ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod
3951000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
33000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1097000
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.115
amrn Operating Lease Change In Weighted Average Discount Rate Percent
OperatingLeaseChangeInWeightedAverageDiscountRatePercent
0.01
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
10500000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10600000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7800000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8100000
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
500000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1500000
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1200000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
405000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1774000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1808000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1842000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1876000
CY2021Q3 amrn Lessee Operating Lease Liability Payments Due Year Five And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter
9112000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
16817000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6358000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1730000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8729000

Files In Submission

Name View Source Status
0000950170-21-002721-index-headers.html Edgar Link pending
0000950170-21-002721-index.html Edgar Link pending
0000950170-21-002721.txt Edgar Link pending
0000950170-21-002721-xbrl.zip Edgar Link pending
amrn-20210930.htm Edgar Link pending
amrn-20210930.xsd Edgar Link pending
amrn-20210930_cal.xml Edgar Link unprocessable
amrn-20210930_def.xml Edgar Link unprocessable
amrn-20210930_htm.xml Edgar Link completed
amrn-20210930_lab.xml Edgar Link unprocessable
amrn-20210930_pre.xml Edgar Link unprocessable
amrn-ex10_1.htm Edgar Link pending
amrn-ex31_1.htm Edgar Link pending
amrn-ex31_2.htm Edgar Link pending
amrn-ex32_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img195770556_0.jpg Edgar Link pending
img195770556_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending